Collectively, we show that TM4SF4 in lung cancer cells mediates the activation of a positive feedback autocrine loop between OPN and STAT3 pathways, resulting in cancer stemness and radiation resistance, and suggest targeting TM4SF4 or OPN may be useful as a cancer treatment. The gene discussed is TM4SF4; the disease is lung cancer.